These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3531945)

  • 1. [The diagnosis of multiple myeloma].
    Bartl R; Fateh-Moghadam A
    Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
    Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.
    Bartl R; Frisch B; Fateh-Moghadam A; Kettner G; Jaeger K; Sommerfeld W
    Am J Clin Pathol; 1987 Mar; 87(3):342-55. PubMed ID: 3825999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Smoldering multiple myeloma].
    Zapatero A; Blanco L; Sevilla F; Fraile G; Montalbán C
    Rev Clin Esp; 1985 May; 176(9):469-70. PubMed ID: 4023335
    [No Abstract]   [Full Text] [Related]  

  • 6. [The diagnostic value of monoclonal proteins in serum].
    Erikssen J; Lingjaerde P
    Tidsskr Nor Laegeforen; 1973 Sep; 93(25):1733-6. PubMed ID: 4771905
    [No Abstract]   [Full Text] [Related]  

  • 7. Unusually prominent M protein in Indian patients with IgD multiple myeloma.
    Inamdar NA; Parikh PM; Hedge RM; Karkhanis VC; Sastry PS; Gopal R; Raste AS; Advani SH
    Acta Haematol; 1995; 94(4):216-7. PubMed ID: 8610482
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathologic studies useful for the diagnosis and monitoring of plasma cell dyscrasias.
    Veillon DM; Cotelingam JD
    Contrib Nephrol; 2007; 153():25-43. PubMed ID: 17075222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients.
    Sailer M; Vykoupil KF; Peest D; Coldewey R; Deicher H; Georgii A
    Eur J Haematol; 1995 Mar; 54(3):137-46. PubMed ID: 7720832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor distribution classification system for multiple myeloma: clinical features and prognosis.
    Sezaki T; Izumi K; Hoshijima T; Adachi T; Takahashi I; Kimura I
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1784-91. PubMed ID: 3564859
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis.
    Pruzanski W; Gidon MS; Roy A
    Clin Immunol Immunopathol; 1980 Oct; 17(2):280-6. PubMed ID: 7408241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic clinical and morphological classification of multiple myeloma (author's transl)].
    Wutke K; Rüdiger KD; Kelényi G
    Arch Geschwulstforsch; 1979; 49(8):671-84. PubMed ID: 543783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM; Wijermans PW
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
    Paule B; Quillard J; Bennet P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
    Pasqualetti P; Colantonio D; Collacciani A; Casale R; Natali G
    Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects of multiple myeloma].
    López Alvarez J; Sanz Marca A; Aboin Massieu FJ
    Rev Clin Esp; 1983 Nov; 171(3):165-74. PubMed ID: 6366936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.